Optimising prostate biopsy.

Current practice of prostate biopsy in Australia and New Zealand: A survey. Urol Ann (2015) 0.81

What about seeding during prostate biopsy? BMJ (2012) 0.75

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ (2012) 4.64

A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy. Eur Urol (2009) 2.47

Incidence of lymphoceles after robot-assisted pelvic lymph node dissection. BJU Int (2011) 2.17

New treatment approaches for prostate cancer based on peptide analogues. Eur Urol (2007) 2.13

Pentafecta: a new concept for reporting outcomes of robot-assisted laparoscopic radical prostatectomy. Eur Urol (2011) 2.12

Assessing the accuracy and generalizability of the preoperative and postoperative Karakiewicz nomograms for renal cell carcinoma: results from a multicentre European and US study. BJU Int (2013) 2.08

Early complication rates in a single-surgeon series of 2500 robotic-assisted radical prostatectomies: report applying a standardized grading system. Eur Urol (2010) 2.04

Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a critical review of outcomes reported by high-volume centers. J Endourol (2010) 2.00

Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients. Eur Urol (2004) 1.89

Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: latest update on alpha-adrenoceptor antagonists. BJU Int (2005) 1.76

Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project). Eur Urol (2012) 1.69

Continence, potency and oncological outcomes after robotic-assisted radical prostatectomy: early trifecta results of a high-volume surgeon. BJU Int (2010) 1.68

Positive surgical margins after robotic assisted radical prostatectomy: a multi-institutional study. J Urol (2011) 1.62

Prevention of prostate cancer with finasteride: US/European perspective. Eur Urol (2003) 1.59

Local active warming: an effective treatment for pain, anxiety and nausea caused by renal colic. J Urol (2003) 1.50

Posterior rhabdosphincter reconstruction during robot-assisted radical prostatectomy: critical analysis of techniques and outcomes. Urology (2010) 1.49

Benign positive margins after radical prostatectomy means a poor prognosis--pro. Urology (2005) 1.43

Perioperative and early oncological outcomes after robot-assisted radical prostatectomy (RARP) in morbidly obese patients: a propensity score-matched study. BJU Int (2013) 1.42

Evaluation of erectile function after laparoscopic radical prostatectomy in a single center. Can J Urol (2012) 1.38

Correlation between benign prostatic hyperplasia and inflammation. Curr Opin Urol (2013) 1.34

Benign prostatic hyperplasia: a progressive disease of aging men. Urology (2003) 1.31

The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol (2005) 1.29

Open Versus Laparoscopic Versus Robot-Assisted Laparoscopic Prostatectomy: The European and US Experience. Rev Urol (2010) 1.25

Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase. Rev Urol (2005) 1.20

α-Blockers for benign prostatic hyperplasia: the new era. Curr Opin Urol (2012) 1.19

Prostate cancer in elderly men. Rev Urol (2008) 1.19

Chemopreventive effects of resveratrol and resveratrol derivatives. Ann N Y Acad Sci (2011) 1.18

Early continence recovery after open radical prostatectomy with restoration of the posterior aspect of the rhabdosphincter. Eur Urol (2007) 1.18

Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials. Rev Urol (2009) 1.12

Open versus robotic-assisted partial nephrectomy: a multicenter comparison study of perioperative results and complications. World J Urol (2013) 1.10

Periurethral suspension stitch during robot-assisted laparoscopic radical prostatectomy: description of the technique and continence outcomes. Eur Urol (2009) 1.10

Predictive factors for positive surgical margins and their locations after robot-assisted laparoscopic radical prostatectomy. Eur Urol (2010) 1.08

The Vista system: a new bipolar resection device for endourological procedures: comparison with conventional resectoscope. Eur Urol (2004) 1.04

11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer. J Clin Oncol (2006) 1.01

Experience with robotic lobectomy for lung cancer. Innovations (Phila) (2011) 1.01

An artificial neural network to predict the outcome of repeat prostate biopsies. Urology (2003) 0.98

Efficacy of oral doxepin and piroxicam treatment for interstitial cystitis. Eur Urol (2002) 0.98

Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy? Eur Urol (2004) 0.98

Synchronous collecting duct carcinoma and papillary renal cell carcinoma: a case report and review of the literature. Anticancer Res (2005) 0.98

Robotic-assisted radical prostatectomy: a review of current outcomes. BJU Int (2009) 0.97

Functional outcomes after treatment for prostate cancer. N Engl J Med (2013) 0.97

Robotic technologies in surgical oncology training and practice. Surg Oncol (2011) 0.95

Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database. World J Urol (2013) 0.94

Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapy. Int J Radiat Oncol Biol Phys (2010) 0.93

An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less. J Urol (2003) 0.92

Artificial neural networks for decision-making in urologic oncology. Eur Urol (2003) 0.91

Management of early prostate cancer. N Engl J Med (2014) 0.91

The picture of the prostatic lymphokine network is becoming increasingly complex. Rev Urol (2002) 0.91

Hormonal manipulation of benign prostatic hyperplasia. Curr Opin Urol (2013) 0.90

Validity and legacy of prostate-specific antigen (PSA) and PSA-based parameters and isoforms in the new millennium. Eur Urol (2010) 0.89

Recent advances in the surgical treatment of benign prostatic hyperplasia. Ther Adv Urol (2011) 0.89

Preliminary analysis of the feasibility and safety of salvage robot-assisted radical prostatectomy after radiation failure: multi-institutional perioperative and short-term functional outcomes. J Endourol (2011) 0.88

Progression of benign prostatic hyperplasia: systematic review of the placebo arms of clinical trials. BJU Int (2008) 0.87

Vitamin D and benign prostatic hyperplasia -- a review. Can J Urol (2013) 0.87

Gene polymorphisms and prostate cancer: the evidence. BJU Int (2009) 0.86

Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy: preliminary report. Eur Urol (2006) 0.86

Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysis. Clin Genitourin Cancer (2013) 0.85

Does the presence of median lobe affect outcomes of robot-assisted laparoscopic radical prostatectomy? J Endourol (2012) 0.84

The role of the prostatic vasculature as a landmark for nerve sparing during robot-assisted radical prostatectomy. Eur Urol (2011) 0.84

European Study of Radical Prostatectomy: time trends in Europe, 1993-2005. BJU Int (2007) 0.83

Novel resveratrol derivatives induce apoptosis and cause cell cycle arrest in prostate cancer cell lines. Anticancer Res (2007) 0.83

Current status of pelvic lymph node dissection in prostate cancer: the New York PLND nomogram. Can J Urol (2011) 0.83

Modified technique of robotic-assisted simple prostatectomy: advantages of a vesico-urethral anastomosis. BJU Int (2011) 0.83

Minimally invasive therapies for benign prostatic hyperplasia in the new millennium: long-term data. Curr Opin Urol (2002) 0.83

Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation. Urol Oncol (2009) 0.82

Urinary continence after radical prostatectomy: the patient perspective. Can J Urol (2011) 0.81

Robotic prostatectomy: facts or fiction? Lancet (2007) 0.81

Benign splenosis mimicking peritoneal seeding in a bladder cancer patient: a case report. Cases J (2009) 0.81

Laser prostatectomy: holmium laser enucleation and photoselective laser vaporization of the prostate. Rev Urol (2013) 0.81

American Urological Association and European Association of Urology guidelines in the management of benign prostatic hypertrophy: revisited. Curr Opin Urol (2012) 0.80

Gefitinib combined with endocrine manipulation in patients with hormone-refractory prostate cancer: quality of life and surrogate markers of activity. Anticancer Drugs (2007) 0.80

Natural history and clinical predictors of clinical progression in benign prostatic hyperplasia. Curr Opin Urol (2005) 0.79

Techniques of nerve-sparing and potency outcomes following robot-assisted laparoscopic prostatectomy. Int Braz J Urol (2010) 0.79

Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future perspectives. BJU Int (2014) 0.79

Intraoperative radiotherapy for locally advanced prostate cancer: treatment technique and ultrasound-based analysis of dose distribution. Anticancer Res (2007) 0.79

Chemopreventive trials in urologic cancer. Rev Urol (2006) 0.78

Locally advanced prostate cancer: biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy. Cancer (2007) 0.78

New findings in localized and advanced prostate cancer: AUA 2011 review. Can J Urol (2011) 0.78

BPH: predicting TWOC failure in acute urinary retention. Nat Rev Urol (2012) 0.78

Robotics in uro-oncologic surgery. Ecancermedicalscience (2013) 0.78

Anatomical reconstruction of the rhabdosphincter after radical prostatectomy. BJU Int (2009) 0.78

Nonabsorbable polymer clip as a cause of chronic perineal pain after radical prostatectomy: Description of a case treated by transperineal approach. Arch Ital Urol Androl (2017) 0.77

Bladder tumours in children: An interesting case report of TCC with a partial inverted growth pattern. Arch Ital Urol Androl (2014) 0.77

Benefit on biochemical control of adjuvant radiation therapy in patients with pathologically involved seminal vesicles after radical prostatectomy. Tumori (2007) 0.77

TriMatch comparison of the efficacy of FloSeal versus TachoSil versus no hemostatic agents for partial nephrectomy: results from a large multicenter dataset. Int J Urol (2014) 0.77

Prostate-specific antigen testing in the new millennium. BJU Int (2005) 0.77

Role of phytotherapy in men with lower urinary tract symptoms. Curr Opin Urol (2005) 0.76

Re: Is tumor volume an independent prognostic factor in clinically localized prostate cancer? J Urol (2005) 0.76

Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men. World J Urol (2007) 0.76

Role of testosterone in managing advanced prostate cancer. Urology (2012) 0.76

A prospective randomized study of combined visual laser ablation and transurethral resection of the prostate versus transurethral prostatectomy alone. Urol Int (2003) 0.76

Editorial comment. Urology (2011) 0.75

Editorial comment. Urology (2011) 0.75

Re: Assessment of early continence after reconstruction of the periprostatic tissues in patients undergoing computer assisted (robotic) prostatectomy: results of a 2 group parallel randomized controlled trial: M. Menon, F. Muhletaler, M. Campos and J. O. Peabody J Urol 2008; 180: 1018-1023. J Urol (2009) 0.75

EDITORIAL COMMENT Re: Can we identify those patients who will benefit from prostate-sparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinoma. Can J Urol (2011) 0.75

New findings in benign prostatic hyperplasia and incontinence: highlights from the 26th annual congress of the European association of urology, march 18-22, 2011, vienna, austria. Rev Urol (2011) 0.75

Re: An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series. J Urol (2004) 0.75

Letter to the Editor; Re: Wirth MP, Weissbach L, Marx F-J, Heckl W, Jellinghaus W, Riedmiller H, Noack B, Hinke A, Froehner M. Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancer. Eur Urol 2004;45:267-70. Eur Urol (2004) 0.75

Autoantibodies in prostate cancer. N Engl J Med (2005) 0.75

Prostate cancer with low PSA levels. N Engl J Med (2004) 0.75

New Findings in Prostate Cancer, Benign Prostatic Hyperplasia, and Sexual Dysfunction: Highlights from the XVIII Congress of the European Association of Urology, March 12-15, 2003, Madrid, Spain. Rev Urol (2004) 0.75